Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Total Liabilities (2023 - 2025)

Baird Medical Investment Holdings has reported Total Liabilities over the past 3 years, most recently at $38.5 million for Q4 2025.

  • For Q4 2025, Total Liabilities rose 0.72% year-over-year to $38.5 million; the TTM value through Dec 2025 reached $38.5 million, up 0.72%, while the annual FY2025 figure was $38.5 million, 0.72% up from the prior year.
  • Total Liabilities for Q4 2025 was $38.5 million at Baird Medical Investment Holdings, down from $41.4 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $41.4 million in Q2 2025 and troughed at $21.0 million in Q4 2023.
  • A 3-year average of $34.8 million and a median of $38.3 million in 2024 define the central range for Total Liabilities.
  • Biggest five-year swings in Total Liabilities: soared 81.91% in 2024 and later grew 0.72% in 2025.
  • Year by year, Total Liabilities stood at $21.0 million in 2023, then skyrocketed by 81.91% to $38.2 million in 2024, then increased by 0.72% to $38.5 million in 2025.
  • Business Quant data shows Total Liabilities for BDMD at $38.5 million in Q4 2025, $41.4 million in Q2 2025, and $38.2 million in Q4 2024.